J. Ostrowski

发表

Determination of the active metabolite of molsidomine in human plasma by reversed-phase high-performance liquid chromatography.

O. Spreux-Varoquaux, C. Advenier, J. Moreau, 1990, Journal of chromatography.

[Autoradiographic studies on the distribution of 14C-piracetam in the simian brain].

M. Keil, J. Ostrowski, 1978, Arzneimittel-Forschung.

Synchronous diagnosis of multiple tumours in a postmenopausal woman

I. Giarenis, J. Ostrowski, N. Burbos, 2009, Archives of Gynecology and Obstetrics.

Sclerotherapy with bleomycin for recurrent massive inguinal lymphoceles following partial vulvectomy and bilateral lymphadenectomy-Case report and literature review.

B. Sharma, J. Ostrowski, D. Elsandabesee, 2004, Gynecologic oncology.

Metastatic Seminoma: Should Treatment Be Different from Non-seminoma?

J. L. Vay, M. Williams, J. Shamash, 2002 .

On the Mechanism of NO Release from Sydnonimines

M. Feelisch, J. Ostrowski, E. Noack, 1989, Journal of cardiovascular pharmacology.

Phorbol ester (12-O-tetradecanoylphorbol 13-acetate) prevents ornithine decarboxylase inhibition and apoptosis and L1210 leukemic cells exposed to TGF-beta 1.

T. Motyl, K. Grzelkowska, M. Filipecki, 1996, The international journal of biochemistry & cell biology.

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer.

W. Scheithauer, C. Tudur-Smith, R. Herrmann, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Idarubicin and cyclophosphamide--an active oral chemotherapy regimen for advanced breast cancer.

A. Howell, D. Cameron, R. Leonard, 2000, Critical reviews in oncology/hematology.

Relationship between pharmacokinetics and pharmacodynamics of molsidomine and its metabolites in humans.

T. Meinertz, D. Trenk, E. Jähnchen, 1985, American heart journal.

Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial

Jacob G. Scott, H. J. Pearson, C. Fuller, 2012 .

Intravenous and oral administration of molsidomine, a pharmacodynamic and pharmacokinetic study

L. Peterson, R. Bergstrand, A. Vedin, 2004, European Journal of Clinical Pharmacology.

Liver function and pharmacokinetics of molsidomine and its metabolite 3-morpholinosydnonimine in healthy volunteers.

J. Chamberlain, H. Stockhausen, J. Ostrowski, 1986, Arzneimittel-Forschung.

Pharmacokinetics of molsidomine in humans.

J. Ostrowski, K. Resag, 1985, American heart journal.

In vivo relevance of a controlled oral release system of Molsidomine

M. Stauch, D. Brockmeier, J. Ostrowski, 1985 .

A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: a study by the Scottish Gynaecological Cancer Trials Group (SGCTG).

C. Poole, S. Kaye, J. Graham, 2006, European journal of cancer.

N-Acetylserotonin prevents the hypotension induced by bacterial lipopolysaccharides in the rat.

T. Morath, P. Klemm, P. Martorana, 1993, European journal of pharmacology.

Determination of pirlindole in plasma and urine by high-performance liquid chromatography.

H. Passing, J. Ostrowski, W. Gärtner, 1984, Journal of Chromatography A.

Mean time and first-pass metabolism

D. Brockmeier, J. Ostrowski, 2004, European Journal of Clinical Pharmacology.

[Lipoprotein regulatory effect of molsodomine in rats].

E. Granzer, J. Ostrowski, 1984, Arzneimittel-Forschung.

Pharmacokinetics of an extended-release dosage form of molsidomine in patients with coronary heart disease

D. Brockmeier, G. Gaul, J. Ostrowski, 2004, European Journal of Clinical Pharmacology.